Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.35 |
| ▸ | HPGD | P15428 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30697920 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1TDP1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL22616816 | 0.99 | KDM4E (0.39) | KDM4EALDH1A1TDP1LMNAMAPT | |
| SCHEMBL28564674 | 0.78 | ALDH1A1 (0.63) | KDM4EALDH1A1TDP1LMNAMAPT | |
| SCHEMBL4302891 | 0.73 | KDM4E (0.40) | KDM4EALDH1A1TDP1LMNAMAPT | |
| SCHEMBL23845864 | 0.65 | GAA (0.38) | KDM4EALDH1A1TDP1LMNAMAPT | |
| SCHEMBL18244163 | 0.64 | — | — | |
| SCHEMBL23418398 | 0.64 | KDM4E (0.42) | KDM4EALDH1A1TDP1LMNAMAPT | |
| SCHEMBL30301203 | 0.63 | — | — | |
| SCHEMBL29207958 | 0.62 | CYP1A2 (0.58) | KDM4EALDH1A1TDP1LMNAMAPT | |
| SCHEMBL24788182 | 0.59 | CA9 (0.47) | KDM4EALDH1A1TDP1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114133387-A | Fluorescent probe with viscosity sensing property and capable of targeting multiple organelles | 郑州大学 | 2022-03-04 | — | — | CN | claimed |
| US-20040264528-A1 | External cavity organic laser | CITICORP NORTH AMERICA, INC., AS AGENT | 2004-12-30 | — | — | US | claimed |
| CN-117590691-A | Photosensitive resin composition | 中央硝子株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-117311090-A | Photosensitive resin composition | 中央硝子株式会社 | 2023-12-29 | — | — | CN | disclosed |
| CN-116508415-A | Light-emitting display device | 乐金显示有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-115583912-A | Carbazole-containing aromatic amine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-115448870-A | Arylamine compound containing carbazole group and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-113383438-B | Organic electroluminescent element | 索路思高新材料有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-113501812-B | Triarylamine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-113270554-A | Organic light emitting display device | 三星显示有限公司 | 2021-08-17 | — | — | CN | disclosed |
| US-20210221903-A1 | BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF | HRAIN BIOTECHNOLOGY CO., LTD. (CN) | 2021-07-22 | — | — | US | disclosed |
| US-20080194522-A1 | Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE | 2008-08-14 | — | — | US | disclosed |
| EP-1914741-A2 | Optical pickup apparatus and optical reproducing method | Funai Electric Co., Ltd. (JP) | 2008-04-23 | — | — | EP | disclosed |
| EP-1912209-A1 | Optical recording medium, recording method of information on optical recording medium and reproducing method thereof | Funai Electric Co., Ltd. (JP) | 2008-04-16 | — | — | EP | disclosed |
| CN-101162596-A | Optical recording medium, recording method of information on optical recording medium and reproducing method thereof | FUNAI ELECTRIC CO (JP) | 2008-04-16 | — | — | CN | disclosed |
| CN-101162592-A | Optical pickup apparatus and optical reproducing method | FUNAI ELECTRIC CO (JP) | 2008-04-16 | — | — | CN | disclosed |
| US-20080084806-A1 | Optical recording medium, recording method of information on optical recording medium and reproducing method thereof | FUNAI ELECTRIC CO., LTD. (JP) | 2008-04-10 | — | — | US | disclosed |
| WO-2006023821-A2 | LIGANDS FOR ALDOKETOREDUCTASES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20050009946-A1 | Radical polymerization catalyst and adhesive kit for dental use | TOKUYAMA CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040246201-A1 | OLED display and pixel structure thereof | AU OPTRONICS CORP. (TW) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194522-A1 | Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) | MAOA, MAOB, COMT | KDM4E 1183/4885ALDH1A1 181/4885TDP1 557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.